NSC639829

CAS No. 134742-19-1

NSC639829( NSC-639829 | NSC 639829 )

Catalog No. M11410 CAS No. 134742-19-1

A potent anticancer agent that demonstrates potent antitumor activity in vitro against several cancer cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
25MG 1444 In Stock
50MG 1841 In Stock
100MG 2325 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC639829
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent anticancer agent that demonstrates potent antitumor activity in vitro against several cancer cell lines.
  • Description
    A potent anticancer agent that demonstrates potent antitumor activity in vitro against several cancer cell lines as well as in vivo against several tumor models, effectively inhibits in vitro tubulin polymerization.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC-639829 | NSC 639829
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    Microtubule/Tubulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    134742-19-1
  • Formula Weight
    470.327
  • Molecular Formula
    C21H20BrN5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC(NC1=CC=C(OC2=NC=C(Br)C=N2)C(C)=C1)=O)C3=CC=CC=C3N(C)C
  • Chemical Name
    N-((4-((5-bromopyrimidin-2-yl)oxy)-3-methylphenyl)carbamoyl)-2-(dimethylamino)benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Abdel-Aziz W, et al. Invest New Drugs. 2003 Nov;21(4):421-8. 2. Jain A, et al. AAPS PharmSciTech. 2003 Oct 15;4(4):E52. 3. Balcer-Kubiczek EK, et al. Cancer Chemother Pharmacol. 2007 May;59(6):781-7. 4. Hallur G, et al. J Med Chem. 2006 Apr 6;49(7):2357-60.
molnova catalog
related products
  • TR-100

    TR-100 (TR100) is a specific anti-tropomyosin compound that disrupts the actin cytoskeleton via targeting of Tpm3.1-containing actin filaments.

  • MAP4343

    Map4343 is a 3-methyl ether derivative of pregnenolone. Map4343 binds to microtubule associated protein 2 (MAP2) in vitro and stimulates tubulin polymerization, resulting in enhanced neurite extension and protection of neurons from neurotoxic agents.

  • Ixabepilone

    A semisynthetic Epothilone B analogue and potent, orally active microtubule stabilizer.